Senator Edward M. Kennedy (D-MA), who will take over leadership of the Senate Committee on Health, Education, Labor, and Pensions when the next Congress is sworn in, is not happy with FDA. Today he will make that known at a hearing on potential FDA reform legislation, reports the Boston Globe. Kennedy told the Globe that he believes FDA too often compromises science for politics and is too concerned with pleasing industry. His remarks seemed aimed at drug regulation, but expect any reform plan to impact devices, too, whether directly or indirectly. One potential positive: Kennedy and his fellow Democrats may choose to do something about the Congressional underfunding that has plagued the agency for years.